Sanofi India Limited
Sanofi India Limited (SANOFI.BO) Stock Competitors & Peer Comparison
See (SANOFI.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SANOFI.BO | ₹3,420.85 | +2.13% | 77.7B | 23.81 | ₹141.70 | +5.68% |
| CIPLA.NS | ₹1,215.90 | +1.25% | 971.3B | 21.36 | ₹56.28 | +1.33% |
| CIPLA.BO | ₹1,215.80 | +1.22% | 971.2B | 21.39 | ₹56.20 | +1.33% |
| ABBOTINDIA.NS | ₹25,850.00 | -0.17% | 545.4B | 35.77 | ₹717.58 | +1.85% |
| ABBOTINDIA.BO | ₹25,853.30 | -0.22% | 545.3B | 36.12 | ₹710.49 | +1.85% |
| GLAXO.NS | ₹2,354.30 | +0.33% | 395.3B | 38.68 | ₹60.33 | +2.31% |
| GLAXO.BO | ₹2,354.75 | +0.35% | 394.9B | 41.41 | ₹56.30 | +2.31% |
| GLAND.NS | ₹1,728.50 | +1.68% | 283.4B | 33.40 | ₹51.50 | +1.05% |
| GLAND.BO | ₹1,729.20 | +1.69% | 282.4B | 33.36 | ₹51.37 | +1.05% |
| PFIZER.NS | ₹4,835.70 | -0.09% | 218.6B | 25.60 | ₹186.69 | +3.45% |
Stock Comparison
SANOFI.BO vs CIPLA.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, CIPLA.NS has a market cap of 971.3B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while CIPLA.NS trades at ₹1,215.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas CIPLA.NS's P/E ratio is 21.36. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to CIPLA.NS's ROE of +0.15%. Regarding short-term risk, SANOFI.BO is more volatile compared to CIPLA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check CIPLA.NS's competition here
SANOFI.BO vs CIPLA.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, CIPLA.BO has a market cap of 971.2B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while CIPLA.BO trades at ₹1,215.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas CIPLA.BO's P/E ratio is 21.39. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to CIPLA.BO's ROE of +0.15%. Regarding short-term risk, SANOFI.BO is less volatile compared to CIPLA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check CIPLA.BO's competition here
SANOFI.BO vs ABBOTINDIA.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, ABBOTINDIA.NS has a market cap of 545.4B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while ABBOTINDIA.NS trades at ₹25,850.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas ABBOTINDIA.NS's P/E ratio is 35.77. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to ABBOTINDIA.NS's ROE of +0.38%. Regarding short-term risk, SANOFI.BO is more volatile compared to ABBOTINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check ABBOTINDIA.NS's competition here
SANOFI.BO vs ABBOTINDIA.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, ABBOTINDIA.BO has a market cap of 545.3B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while ABBOTINDIA.BO trades at ₹25,853.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas ABBOTINDIA.BO's P/E ratio is 36.12. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to ABBOTINDIA.BO's ROE of +0.38%. Regarding short-term risk, SANOFI.BO is more volatile compared to ABBOTINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check ABBOTINDIA.BO's competition here
SANOFI.BO vs GLAXO.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, GLAXO.NS has a market cap of 395.3B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while GLAXO.NS trades at ₹2,354.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas GLAXO.NS's P/E ratio is 38.68. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to GLAXO.NS's ROE of +0.56%. Regarding short-term risk, SANOFI.BO is more volatile compared to GLAXO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check GLAXO.NS's competition here
SANOFI.BO vs GLAXO.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, GLAXO.BO has a market cap of 394.9B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while GLAXO.BO trades at ₹2,354.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas GLAXO.BO's P/E ratio is 41.41. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to GLAXO.BO's ROE of +0.56%. Regarding short-term risk, SANOFI.BO is more volatile compared to GLAXO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check GLAXO.BO's competition here
SANOFI.BO vs GLAND.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, GLAND.NS has a market cap of 283.4B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while GLAND.NS trades at ₹1,728.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas GLAND.NS's P/E ratio is 33.40. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to GLAND.NS's ROE of +0.09%. Regarding short-term risk, SANOFI.BO is less volatile compared to GLAND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check GLAND.NS's competition here
SANOFI.BO vs GLAND.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, GLAND.BO has a market cap of 282.4B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while GLAND.BO trades at ₹1,729.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas GLAND.BO's P/E ratio is 33.36. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to GLAND.BO's ROE of +0.09%. Regarding short-term risk, SANOFI.BO is less volatile compared to GLAND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check GLAND.BO's competition here
SANOFI.BO vs PFIZER.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, PFIZER.NS has a market cap of 218.6B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while PFIZER.NS trades at ₹4,835.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas PFIZER.NS's P/E ratio is 25.60. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to PFIZER.NS's ROE of +0.21%. Regarding short-term risk, SANOFI.BO is more volatile compared to PFIZER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check PFIZER.NS's competition here
SANOFI.BO vs PFIZER.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, PFIZER.BO has a market cap of 218.5B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while PFIZER.BO trades at ₹4,829.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas PFIZER.BO's P/E ratio is 26.05. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to PFIZER.BO's ROE of +0.21%. Regarding short-term risk, SANOFI.BO is more volatile compared to PFIZER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check PFIZER.BO's competition here
SANOFI.BO vs SANOFICONR.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, SANOFICONR.NS has a market cap of 104.3B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while SANOFICONR.NS trades at ₹4,479.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas SANOFICONR.NS's P/E ratio is 43.40. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to SANOFICONR.NS's ROE of +0.79%. Regarding short-term risk, SANOFI.BO is less volatile compared to SANOFICONR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check SANOFICONR.NS's competition here
SANOFI.BO vs SANOFI.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, SANOFI.NS has a market cap of 77.9B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while SANOFI.NS trades at ₹3,419.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas SANOFI.NS's P/E ratio is 23.86. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to SANOFI.NS's ROE of +0.37%. Regarding short-term risk, SANOFI.BO is more volatile compared to SANOFI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check SANOFI.NS's competition here
SANOFI.BO vs MARKSANS.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, MARKSANS.NS has a market cap of 77B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while MARKSANS.NS trades at ₹174.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas MARKSANS.NS's P/E ratio is 21.38. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to MARKSANS.NS's ROE of +0.14%. Regarding short-term risk, SANOFI.BO is more volatile compared to MARKSANS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check MARKSANS.NS's competition here
SANOFI.BO vs MARKSANS.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, MARKSANS.BO has a market cap of 76.7B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while MARKSANS.BO trades at ₹174.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas MARKSANS.BO's P/E ratio is 21.81. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to MARKSANS.BO's ROE of +0.14%. Regarding short-term risk, SANOFI.BO is less volatile compared to MARKSANS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check MARKSANS.BO's competition here
SANOFI.BO vs SMSPHARMA.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, SMSPHARMA.BO has a market cap of 36.6B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while SMSPHARMA.BO trades at ₹398.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas SMSPHARMA.BO's P/E ratio is 38.96. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to SMSPHARMA.BO's ROE of +0.14%. Regarding short-term risk, SANOFI.BO is more volatile compared to SMSPHARMA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check SMSPHARMA.BO's competition here
SANOFI.BO vs SMSPHARMA.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, SMSPHARMA.NS has a market cap of 36.5B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while SMSPHARMA.NS trades at ₹399.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas SMSPHARMA.NS's P/E ratio is 38.93. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to SMSPHARMA.NS's ROE of +0.14%. Regarding short-term risk, SANOFI.BO is less volatile compared to SMSPHARMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check SMSPHARMA.NS's competition here
SANOFI.BO vs SENORES.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, SENORES.NS has a market cap of 35.6B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while SENORES.NS trades at ₹783.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas SENORES.NS's P/E ratio is 30.03. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to SENORES.NS's ROE of +0.13%. Regarding short-term risk, SANOFI.BO is more volatile compared to SENORES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANOFI.BO.Check SENORES.NS's competition here
SANOFI.BO vs NGLFINE.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, NGLFINE.NS has a market cap of 13.7B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while NGLFINE.NS trades at ₹2,331.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas NGLFINE.NS's P/E ratio is 38.71. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to NGLFINE.NS's ROE of +0.12%. Regarding short-term risk, SANOFI.BO is less volatile compared to NGLFINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check NGLFINE.NS's competition here
SANOFI.BO vs NGLFINE.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, NGLFINE.BO has a market cap of 13.7B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while NGLFINE.BO trades at ₹2,337.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas NGLFINE.BO's P/E ratio is 38.62. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to NGLFINE.BO's ROE of +0.12%. Regarding short-term risk, SANOFI.BO is less volatile compared to NGLFINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check NGLFINE.BO's competition here
SANOFI.BO vs TTKHLTCARE.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, TTKHLTCARE.NS has a market cap of 11.5B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while TTKHLTCARE.NS trades at ₹886.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas TTKHLTCARE.NS's P/E ratio is 19.16. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to TTKHLTCARE.NS's ROE of +0.06%. Regarding short-term risk, SANOFI.BO is less volatile compared to TTKHLTCARE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check TTKHLTCARE.NS's competition here
SANOFI.BO vs KOPRAN.BO Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, KOPRAN.BO has a market cap of 6.5B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while KOPRAN.BO trades at ₹146.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas KOPRAN.BO's P/E ratio is 39.34. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to KOPRAN.BO's ROE of +0.03%. Regarding short-term risk, SANOFI.BO is less volatile compared to KOPRAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check KOPRAN.BO's competition here
SANOFI.BO vs KOPRAN.NS Comparison April 2026
SANOFI.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SANOFI.BO stands at 77.7B. In comparison, KOPRAN.NS has a market cap of 6.5B. Regarding current trading prices, SANOFI.BO is priced at ₹3,420.85, while KOPRAN.NS trades at ₹146.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SANOFI.BO currently has a P/E ratio of 23.81, whereas KOPRAN.NS's P/E ratio is 39.27. In terms of profitability, SANOFI.BO's ROE is +0.37%, compared to KOPRAN.NS's ROE of +0.03%. Regarding short-term risk, SANOFI.BO is less volatile compared to KOPRAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANOFI.BO.Check KOPRAN.NS's competition here